These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2001699)
1. Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus. Wawrzynczak EJ; Henry RV; Cumber AJ; Parnell GD; Derbyshire EJ; Ulbrich N Eur J Biochem; 1991 Feb; 196(1):203-9. PubMed ID: 2001699 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201 [TBL] [Abstract][Full Text] [Related]
3. Comparative biochemical, cytotoxic and pharmacokinetic properties of immunotoxins made with native ricin A chain, ricin A1 chain and recombinant ricin A chain. Wawrzynczak EJ; Cumber AJ; Henry RV; Parnell GD Int J Cancer; 1991 Jan; 47(1):130-5. PubMed ID: 1985869 [TBL] [Abstract][Full Text] [Related]
4. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography. Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254 [TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-sarcin and ribosome-inactivating proteins on the interaction of elongation factors with ribosomes. Brigotti M; Rambelli F; Zamboni M; Montanaro L; Sperti S Biochem J; 1989 Feb; 257(3):723-7. PubMed ID: 2930482 [TBL] [Abstract][Full Text] [Related]
6. The ribosomes of Aspergillus giganteus are sensitive to the cytotoxic action of alpha-sarcin. Miller SP; Bodley JW FEBS Lett; 1988 Mar; 229(2):388-90. PubMed ID: 3345849 [TBL] [Abstract][Full Text] [Related]
7. Conformational changes in the structure of domains II and V of 28S rRNA in ribosomes treated with the translational inhibitors ricin or alpha-sarcin. Larsson SL; Sloma MS; Nygård O Biochim Biophys Acta; 2002 Aug; 1577(1):53-62. PubMed ID: 12151095 [TBL] [Abstract][Full Text] [Related]
8. Fractionation of the ribosome inactivating protein preparations with triazine dyes. Muñoz SM; Caldera M; Canevari S; Tosi E; Cogliati T; Colnaghi MI; Conde FP Biochem Biophys Res Commun; 1990 Dec; 173(2):554-60. PubMed ID: 2260968 [TBL] [Abstract][Full Text] [Related]
9. Production and characterization of a monoclonal antibody against the ribosome inactivating protein alpha sarcin. Ferreri AJ; Ferraris di Celle E; Caldera M; Muñoz S; Salvarelli S; Conde F; Canevari S; Tosi E; Colnaghi MI Hybridoma; 1992 Aug; 11(4):437-46. PubMed ID: 1383124 [TBL] [Abstract][Full Text] [Related]
10. Alpha-sarcin impairs the N-glycosidase activity of ricin on ribosomes. Sperti S; Zamboni M; Brigotti M; Rambelli F; Montanaro L Biochem Biophys Res Commun; 1989 Apr; 160(2):857-61. PubMed ID: 2719703 [TBL] [Abstract][Full Text] [Related]
11. Kinetic study of the cytotoxic effect of alpha-sarcin, a ribosome inactivating protein from Aspergillus giganteus, on tumour cell lines: protein biosynthesis inhibition and cell binding. Turnay J; Olmo N; Jiménez A; Lizarbe MA; Gavilanes JG Mol Cell Biochem; 1993 May; 122(1):39-47. PubMed ID: 8350862 [TBL] [Abstract][Full Text] [Related]
12. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins. Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989 [TBL] [Abstract][Full Text] [Related]
13. Characterization of prokaryotic recombinant Aspergillus ribotoxin alpha-sarcin. Sylvester ID; Roberts LM; Lord JM Biochim Biophys Acta; 1997 Aug; 1358(1):53-60. PubMed ID: 9296521 [TBL] [Abstract][Full Text] [Related]
14. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899 [TBL] [Abstract][Full Text] [Related]
16. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin. Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970 [TBL] [Abstract][Full Text] [Related]
17. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells. Conde FP; Orlandi R; Canevari S; Mezzanzanica D; Ripamonti M; Muñoz SM; Jorge P; Colnaghi MI Eur J Biochem; 1989 Jan; 178(3):795-802. PubMed ID: 2783572 [TBL] [Abstract][Full Text] [Related]
18. [The mechanisms of action of the cytotoxic proteins, alpha-sarcin and ricin A-chain on eukaryotic ribosomes]. Endo Y Seikagaku; 1989 Oct; 61(10):1209-23. PubMed ID: 2693549 [No Abstract] [Full Text] [Related]
19. Ricin and alpha-sarcin alter the conformation of 60S ribosomal subunits at neighboring but different sites. Terao K; Uchiumi T; Endo Y; Ogata K Eur J Biochem; 1988 Jun; 174(3):459-63. PubMed ID: 3391162 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer. Derbyshire EJ; Stahel RA; Wawrzynczak EJ Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]